REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) > Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai > Five-membered Hetero Ring Containing At Least One Nitrogen Ring Atom (e.g., 1,2,3-triazoles, Etc.) > 1,2,5-thiadiazoles (including Hydrogenated) 1,2,5-thiadiazoles (including Hydrogenated)1,2,5-thiadiazoles (including Hydrogenated) patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.01/25/07 - 20070021476 - Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems. Formula I: ... 01/18/07 - 20070015801 - N-aryl-2-oxazolidinone-5-carboxamides and their derivatives The present invention provides antibacterial agents having the formulae I, II, and III described herein. ... 01/04/07 - 20070004785 - Modulators of sperm hypermotility and uses thereof The invention provides novel compositions and compounds that inhibit CatSper channel activity, that preferentially inhibits sperm hyperactivity over sperm motility, or both. The compounds of the invention are useful as contraceptive agents that may be adminstered to males, females, or concurrently to both sexual partners. The invention further provides methods ... 12/28/06 - 20060293370 - Sulfonamide compounds and uses thereof Compounds that modulate GHS-R are described, for examples compounds formula (I) ... 11/16/06 - 20060258719 - Modulators of indoleamine 2,3-dioxygenase and methods of using the same The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof. ... 11/09/06 - 20060252807 - Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders The present invention relates to compounds and methods useful as inhibitors of p38 kinase for the treatment or prevention and treatment of diseases such as inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, angiogenic disorders, infectious diseases, neurodegenerative diseases, and viral diseases. ... 10/12/06 - 20060229343 - Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists B is a oxadiazole or thiadiazole group. ... 08/31/06 - 20060194850 - Novel azole compound wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic ... 08/24/06 - 20060189666 - Novel gamma-secretase inhibitors Compounds of Formula (I): inhibit the processing of APP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease. ... 08/03/06 - 20060173055 - Pyrrole compounds useful as kinase inhibitors The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds, processes for making the compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. ... 08/03/06 - 20060173054 - Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase in which X is a 5-membered heteroaryl ring and R is as defined herein. The compounds are inhibitors of the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease. ... 07/13/06 - 20060154973 - Substituted heteroaryl amide modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof including all stereoisomers thereof, tautomers thereof, or a prodrug thereof, or a pharmaceutically acceptable salt thereof, wherein X is selected from N, O, and S; Y is N or CR6; Z is a ring; and where R, Ra, Rb, Rc, Rd, R1, R2, R3, R4, and R5 are as defined ... 07/06/06 - 20060148863 - Substituted 1,2,4-oxadiazoles, compositions and methods of use Novel 1,2,4-oxadiazole benzoic acid compounds, methods of using and pharmaceutical compositions comprising an 1,2,4-oxadiazole benzoic acid derivative are disclosed. The methods include methods of treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay, or ameliorating one or more symptoms associated therewith. ... 07/06/06 - 20060148862 - Novel compounds that modulate ppary type receptors and cosmetic/pharmaceutical compositions comprised thereof are useful in a wide variety of applications in human or veterinary medicine (in dermatology, and also in the fields of cardiovascular diseases, immune diseases and/or diseases associated with lipid metabolism), or, alternatively are formulated into cosmetic compositions. ... 07/06/06 - 20060148861 - Amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid The invention relates to new 2,2,3,3-tetramethylcyclopropane carboxamide derivative compounds, pharmaceutical compositions thereof and uses thereof for treating psychotic disorders, neurodegenerative diseases, epilepsy and pain. ... 06/22/06 - 20060135571 - Imidazo(2,1-b)-1,3,4-thiadiazole sulfoxides and sulfones This invention relates to novel imidazo[2,1-b]-1,3,4-thiadiazole sulfoxide and sulfone compounds of Formula (I) and the use of compounds of Formula (I) in the treatment of neuronal disorders of the central and peripheral nervous systems and for the treatment of proliferative diseases such as cancer. ... 06/22/06 - 20060135570 - Cyclic sulfamides for inhibiton of gamma-secretase inhibit the processing of AP by gamma-secretase, and hence are useful for treatment or prevention of Alzheimer's disease. ... 06/01/06 - 20060116405 - Indol derivatives and their use as 5-ht ligands The invention relates to indol derivatives of Formula (I) in which R1, R2, R3, X, A, n, m and p have the meanings indicated above. ... 04/20/06 - 20060084687 - Indole and benzimidazole derivatives The present invention relates to new indole and benzimidazole compounds and pharmaceutically acceptable salts, esters or prodrugs thereof, compositions of the new compounds together with pharmaceutically acceptable carriers, and uses of the new compounds. The compounds of the invention have the following general formula: ... 04/13/06 - 20060079562 - Heterocyclic aromatic compounds useful as growth hormone secretagogues The compounds provided herein are useful in treating obesity, osteoporosis (improving bone density) and in improving muscle mass and muscle strength. ... 04/06/06 - 20060074113 - Thiadiazoline derivative Antitumor agents which comprises a thiadiazoline derivative represented by the aforementioned general formula (I) or a pharmacologically acceptable salt thereof as an active ingredient are provided. ... 03/23/06 - 20060063813 - Organic compounds A pharmaceutical composition for treatment of pain, comprises in combination a benzothiadiazole derivative as defined and a COX-2 inhibitor for simultaneous, sequential or separate use. Also provided is a method of treating a patient suffering from pain, comprising administering to the patient an effective amount of a benzothiadiazole derivative as ... 03/09/06 - 20060052422 - 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same wherein, R1 represents C3-C7 alkynyl that may be substituted with halogen atom; R2 represents C3-C8 cycloalkyl which may be substituted with C1-C4 alkyl, halogen atom and trifluoromethyl or the like; A1 represents a single bond, C1-C2 alkylene or C2-C3 alkylidene. The 1,2,4-thiadiazole compound has an excellent arthropod controlling activity, and ... 01/12/06 - 20060009500 - Antiproliferative 1,2,3-thiadiazole compounds and including stereoisomers, solvates, and pharmaceutically acceptable salts thereof, wherein each of R1, R2, R3 and R4 is independently selected from hydrogen, R5, R6, and R7; R5 is selected from alkyl, heteroalkyl, aryl and heteroaryl; R6 is selected from (R5)n-alkylene, (R5)n-heteroalkylene, (R5)n-arylene and (R5)n-heteroarylene; R7 is selected from (R6)n-alkylene, (R6)n-heteroalkylene, ... 12/22/05 - 20050282872 - Novel thyroid receptor ligands and method ii New thyroid receptor ligands are provided which have general formula (I) in which: n is an integer from 0 to 4; R1 is halogen, trifluoromethyl, or alkyl of 1 to 6 carbons or cycloalkyl of 3 to 7 carbons; R2 and R3 are the same or differential hydrogen, halogen, alkyl ... 11/17/05 - 20050256174 - Raf kinase inhibitors Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se. ... 10/20/05 - 20050234111 - D-homo-17-chlor-16(17)-ene steroids process for their production and pharmaceutical compositions that contain these compounds, as well as their use for the production of pharmaceutical agents. ... 10/06/05 - 20050222220 - Gsk-3 inhibitors wherein R1 is an organic group having at least 8 atoms selected from C or O, which is not linked directly to the N through a —C(O)— and comprising at least an aromatic ring, and their pharmaceutical compositions. These compounds are selective GSK-3 inhibitors and have improved bioavailability. They are ... 10/06/05 - 20050222219 - Thiadiazole-amine compounds for the treatment of neurodegenerative disorders wherein R1, R3, R5, R7, X, Y and U are as defined. Compounds of the Formula I have activity inhibiting production of Aβ-peptide. The invention also relates to pharmaceutical compositions and methods of treating diseases and disorders, for example, neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal comprising ... 09/29/05 - 20050215602 - Alkynly-substituted spirocyclic sulfamides for the treatment of alzheimer's disease Compounds of formula (I) are disclosed. The compounds inhibit gamma-secretase and hence find use in treatment of Alzheimer's disease. ... 08/25/05 - 20050187268 - Non-peptidyl agents with phsp20-like activity, and uses thereof The present invention provides compositions and methods for modulating smooth muscle cells. The present invention also provides methods of identifying small molecule candidate therapeutic agents for modulating smooth muscle. ... 08/25/05 - 20050187267 - Sulfonylpyrrolidine modulators of androgen receptor function and method Z is oxygen (—O—) or NR4h, a prodrug ester, all stereoisomers thereof and a pharmaceutically acceptable salt. A method for treating androgen receptor-associated conditions such as age-related diseases is also provided. ... 08/18/05 - 20050182109 - Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase Compounds of formula I are disclosed: in which X is a 5-membered heteroaryl ring and R is as defined herein. The compounds are inhibitors of the processing of APP by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease. ... 07/07/05 - 20050148640 - Aminofurazan compounds useful as protein kinase inhibitors The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. ... 06/09/05 - 20050124671 - Benzylcycloalkyl amines as modulators of chemokine receptor activity or pharmaceutically acceptable salt forms thereof, useful for the prevention of inflammatory diseases such as asthma and other allergic diseases. ... ### FreshPatents.com Support |